Header Logo

Connection

JEFFREY ROSEN to Animals

Back to Details
This is a "connection" page, showing publications JEFFREY ROSEN has written about Animals.
JEFFREY ROSEN
Connection Strength
2.306
Animals
  1. Histone acetylation modulators in breast cancer. Breast Cancer Res. 2025 Mar 31; 27(1):49.
    View in: PubMed
    Score: 0.052
  2. CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
    View in: PubMed
    Score: 0.050
  3. Leveraging preclinical models of metastatic breast cancer. Biochim Biophys Acta Rev Cancer. 2024 09; 1879(5):189163.
    View in: PubMed
    Score: 0.049
  4. Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.047
  5. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer. Cancer Immunol Res. 2023 11 01; 11(11):1462-1479.
    View in: PubMed
    Score: 0.047
  6. Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer. Cancer Res. 2022 06 15; 82(12):2281-2297.
    View in: PubMed
    Score: 0.043
  7. Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics. Cancer Res Commun. 2021 12; 1(3):178-193.
    View in: PubMed
    Score: 0.041
  8. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nat Commun. 2021 07 12; 12(1):4262.
    View in: PubMed
    Score: 0.040
  9. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells. 2020 12 23; 10(1).
    View in: PubMed
    Score: 0.039
  10. New twists on long noncoding RNAs: from mobile elements to motile cancer cells. RNA Biol. 2020 11; 17(11):1535-1549.
    View in: PubMed
    Score: 0.037
  11. C/EBP? Isoform Specific Gene Regulation: It's a Lot more Complicated than you Think! J Mammary Gland Biol Neoplasia. 2020 03; 25(1):1-12.
    View in: PubMed
    Score: 0.036
  12. Alterations in Wnt- and/or STAT3 signaling pathways and the immune microenvironment during metastatic progression. Oncogene. 2019 08; 38(31):5942-5958.
    View in: PubMed
    Score: 0.035
  13. miR-205 Regulates Basal Cell Identity and Stem Cell Regenerative Potential During Mammary Reconstitution. Stem Cells. 2018 12; 36(12):1875-1889.
    View in: PubMed
    Score: 0.033
  14. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res. 2018 08 01; 78(15):4229-4240.
    View in: PubMed
    Score: 0.032
  15. WNT-Mediated Regulation of FOXO1 Constitutes a Critical Axis Maintaining Pubertal Mammary Stem Cell Homeostasis. Dev Cell. 2017 11 20; 43(4):436-448.e6.
    View in: PubMed
    Score: 0.031
  16. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene. 2017 10 26; 36(43):5958-5968.
    View in: PubMed
    Score: 0.030
  17. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states. BMC Biol. 2016 06 17; 14:47.
    View in: PubMed
    Score: 0.028
  18. Effects of oxytocin on background anxiety in rats with high or low baseline startle. Psychopharmacology (Berl). 2016 06; 233(11):2165-2172.
    View in: PubMed
    Score: 0.028
  19. Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer. Breast Cancer Res. 2015 Nov 18; 17:141.
    View in: PubMed
    Score: 0.027
  20. PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland. Dev Biol. 2016 Jan 01; 409(1):202-217.
    View in: PubMed
    Score: 0.027
  21. Changes in dam and pup behavior following repeated postnatal exposure to a predator odor (TMT): A preliminary investigation in Long-Evans rats. Dev Psychobiol. 2016 Mar; 58(2):176-84.
    View in: PubMed
    Score: 0.027
  22. Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage. Stem Cell Reports. 2015 Sep 08; 5(3):378-91.
    View in: PubMed
    Score: 0.027
  23. The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes. Endocr Relat Cancer. 2015 Dec; 22(6):T161-76.
    View in: PubMed
    Score: 0.026
  24. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential. Oncogene. 2015 Dec 03; 34(49):5997-6006.
    View in: PubMed
    Score: 0.026
  25. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Cancer Discov. 2015 May; 5(5):520-33.
    View in: PubMed
    Score: 0.026
  26. Ror2 regulates branching, differentiation, and actin-cytoskeletal dynamics within the mammary epithelium. J Cell Biol. 2015 Feb 02; 208(3):351-66.
    View in: PubMed
    Score: 0.026
  27. Plk2 regulates mitotic spindle orientation and mammary gland development. Development. 2014 Apr; 141(7):1562-71.
    View in: PubMed
    Score: 0.024
  28. Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity? Breast Cancer Res. 2014 Jan 29; 16(1):202.
    View in: PubMed
    Score: 0.024
  29. Pygopus 2: tilting the Wnt-Notch balance in mammary epithelial lineage determination. Breast Cancer Res. 2013 Dec 23; 15(6):322.
    View in: PubMed
    Score: 0.024
  30. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells. 2013 Jan; 31(1):178-89.
    View in: PubMed
    Score: 0.022
  31. Pregnancy-induced noncoding RNA (PINC) associates with polycomb repressive complex 2 and regulates mammary epithelial differentiation. PLoS Genet. 2012; 8(7):e1002840.
    View in: PubMed
    Score: 0.022
  32. On murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol. 2012 Apr 01; 4(4):a013268.
    View in: PubMed
    Score: 0.021
  33. Noncoding RNAs involved in mammary gland development and tumorigenesis: there's a long way to go. J Mammary Gland Biol Neoplasia. 2012 Mar; 17(1):43-58.
    View in: PubMed
    Score: 0.021
  34. On hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2012 Feb 01; 4(2).
    View in: PubMed
    Score: 0.021
  35. Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration. PLoS One. 2011; 6(11):e27841.
    View in: PubMed
    Score: 0.021
  36. P190A RhoGAP is required for mammary gland development. Dev Biol. 2011 Dec 01; 360(1):1-10.
    View in: PubMed
    Score: 0.020
  37. Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model. Cancer Biol Ther. 2011 Aug 15; 12(4):278-87.
    View in: PubMed
    Score: 0.020
  38. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2778-83.
    View in: PubMed
    Score: 0.020
  39. Wnt and mammary stem cells: hormones cannot fly wingless. Curr Opin Pharmacol. 2010 Dec; 10(6):643-9.
    View in: PubMed
    Score: 0.019
  40. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med. 2010 Oct 27; 2(55):55ra79.
    View in: PubMed
    Score: 0.019
  41. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res. 2010 Jun 15; 70(12):4868-79.
    View in: PubMed
    Score: 0.019
  42. The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol. 2010 May-Jun; 7(3):300-4.
    View in: PubMed
    Score: 0.019
  43. CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland. Stem Cells. 2010 Mar 31; 28(3):535-44.
    View in: PubMed
    Score: 0.018
  44. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. J Mammary Gland Biol Neoplasia. 2010 Jun; 15(2):253-60.
    View in: PubMed
    Score: 0.018
  45. Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3522-7.
    View in: PubMed
    Score: 0.018
  46. A putative role for microRNA-205 in mammary epithelial cell progenitors. J Cell Sci. 2010 Feb 15; 123(Pt 4):606-18.
    View in: PubMed
    Score: 0.018
  47. Chk1 haploinsufficiency results in anemia and defective erythropoiesis. PLoS One. 2010 Jan 05; 5(1):e8581.
    View in: PubMed
    Score: 0.018
  48. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Res. 2009; 11(4):R61.
    View in: PubMed
    Score: 0.018
  49. Regulation of casein messenger RNA during the development of the rat mammary gland. 1975. J Mammary Gland Biol Neoplasia. 2009 Sep; 14(3):343-51.
    View in: PubMed
    Score: 0.018
  50. Chking and executing cell division to prevent genomic instability. Cell Cycle. 2009 Aug; 8(15):2339-42.
    View in: PubMed
    Score: 0.018
  51. The increasing complexity of the cancer stem cell paradigm. Science. 2009 Jun 26; 324(5935):1670-3.
    View in: PubMed
    Score: 0.017
  52. Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem. 2009 Aug 21; 284(34):22815-24.
    View in: PubMed
    Score: 0.017
  53. The DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis. Proc Natl Acad Sci U S A. 2009 Mar 31; 106(13):5159-64.
    View in: PubMed
    Score: 0.017
  54. Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Res. 2008 Jun 15; 68(12):4674-82.
    View in: PubMed
    Score: 0.016
  55. Minireview: hormones and mammary cell fate--what will I become when I grow up? Endocrinology. 2008 Sep; 149(9):4317-21.
    View in: PubMed
    Score: 0.016
  56. Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007 Sep; 7(9):659-72.
    View in: PubMed
    Score: 0.015
  57. Crosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud development. Dev Biol. 2007 Sep 01; 309(1):137-49.
    View in: PubMed
    Score: 0.015
  58. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol Endocrinol. 2007 Apr; 21(4):987-1000.
    View in: PubMed
    Score: 0.015
  59. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci. 2007 Feb 01; 120(Pt 3):468-77.
    View in: PubMed
    Score: 0.015
  60. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A. 2007 Jan 09; 104(2):618-23.
    View in: PubMed
    Score: 0.015
  61. Keratin 6 is not essential for mammary gland development. Breast Cancer Res. 2006; 8(3):R29.
    View in: PubMed
    Score: 0.014
  62. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol Endocrinol. 2006 Oct; 20(10):2355-68.
    View in: PubMed
    Score: 0.014
  63. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 2006 Jun 01; 66(11):5676-85.
    View in: PubMed
    Score: 0.014
  64. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc Natl Acad Sci U S A. 2006 Apr 11; 103(15):5781-6.
    View in: PubMed
    Score: 0.014
  65. P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland. Mol Endocrinol. 2006 Jun; 20(6):1391-405.
    View in: PubMed
    Score: 0.014
  66. Stop! In the name of transforming growth factor-beta: keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating. Breast Cancer Res. 2006; 8(4):106.
    View in: PubMed
    Score: 0.014
  67. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol. 2005 Nov 21; 171(4):663-73.
    View in: PubMed
    Score: 0.014
  68. Transcriptional profiling of mammary gland side population cells. Stem Cells. 2006 Apr; 24(4):1065-74.
    View in: PubMed
    Score: 0.014
  69. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice. J Biol Chem. 2005 Oct 28; 280(43):36301-9.
    View in: PubMed
    Score: 0.013
  70. On mammary stem cells. J Cell Sci. 2005 Aug 15; 118(Pt 16):3585-94.
    View in: PubMed
    Score: 0.013
  71. Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
    View in: PubMed
    Score: 0.013
  72. Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2005 Jan; 10(1):17-24.
    View in: PubMed
    Score: 0.013
  73. Chk1 versus Cdc25: chking one's levels of cellular proliferation. Cell Cycle. 2004 Nov; 3(11):1355-7.
    View in: PubMed
    Score: 0.013
  74. IRE1a silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024 Dec 12; 187(25):7248-7266.e34.
    View in: PubMed
    Score: 0.013
  75. Will cancer stem cells provide new therapeutic targets? Carcinogenesis. 2005 Apr; 26(4):703-11.
    View in: PubMed
    Score: 0.013
  76. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell. 2004 Jul; 6(1):45-59.
    View in: PubMed
    Score: 0.012
  77. Multispecies comparative analysis of a mammalian-specific genomic domain encoding secretory proteins. Genomics. 2003 Oct; 82(4):417-32.
    View in: PubMed
    Score: 0.012
  78. Isolation and characterization of functional mammary gland stem cells. Cell Prolif. 2003 Oct; 36 Suppl 1:17-32.
    View in: PubMed
    Score: 0.012
  79. Pregnancy-induced changes in cell-fate in the mammary gland. Breast Cancer Res. 2003; 5(4):192-7.
    View in: PubMed
    Score: 0.011
  80. Transcription factors. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):143-4.
    View in: PubMed
    Score: 0.011
  81. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia. 2003 Apr; 8(2):191-204.
    View in: PubMed
    Score: 0.011
  82. A beta-catenin survival signal is required for normal lobular development in the mammary gland. J Cell Sci. 2003 Mar 15; 116(Pt 6):1137-49.
    View in: PubMed
    Score: 0.011
  83. p190-B RhoGAP regulates mammary ductal morphogenesis. Mol Endocrinol. 2003 Jun; 17(6):1054-65.
    View in: PubMed
    Score: 0.011
  84. LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells. Cancer Immunol Res. 2023 02 03; 11(2):171-183.
    View in: PubMed
    Score: 0.011
  85. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol. 2002 Dec; 16(12):2675-91.
    View in: PubMed
    Score: 0.011
  86. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene. 2022 11; 41(48):5214-5222.
    View in: PubMed
    Score: 0.011
  87. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J Cell Biol. 2002 May 13; 157(4):703-14.
    View in: PubMed
    Score: 0.011
  88. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021 07; 125(2):176-189.
    View in: PubMed
    Score: 0.010
  89. Cooperative effects of STAT5 (signal transducer and activator of transcription 5) and C/EBPbeta (CCAAT/enhancer-binding protein-beta) on beta-casein gene transcription are mediated by the glucocorticoid receptor. Mol Endocrinol. 2001 Feb; 15(2):228-40.
    View in: PubMed
    Score: 0.010
  90. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.
    View in: PubMed
    Score: 0.010
  91. Protein quality control through endoplasmic reticulum-associated degradation maintains haematopoietic stem cell identity and niche interactions. Nat Cell Biol. 2020 10; 22(10):1162-1169.
    View in: PubMed
    Score: 0.009
  92. Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasis. Nat Cancer. 2020 07; 1(7):709-722.
    View in: PubMed
    Score: 0.009
  93. Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer. J Vis Exp. 2020 05 18; (159).
    View in: PubMed
    Score: 0.009
  94. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nat Cell Biol. 2019 09; 21(9):1113-1126.
    View in: PubMed
    Score: 0.009
  95. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor. Dis Model Mech. 2019 07 05; 12(7).
    View in: PubMed
    Score: 0.009
  96. Metastasis Organotropism: Redefining the Congenial Soil. Dev Cell. 2019 05 06; 49(3):375-391.
    View in: PubMed
    Score: 0.009
  97. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol. 1999 Feb; 13(2):330-43.
    View in: PubMed
    Score: 0.008
  98. A transgenic mouse model for mammary carcinogenesis. Oncogene. 1998 Feb 26; 16(8):997-1007.
    View in: PubMed
    Score: 0.008
  99. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. J Clin Invest. 2018 04 02; 128(4):1283-1299.
    View in: PubMed
    Score: 0.008
  100. Composite response elements mediate hormonal and developmental regulation of milk protein gene expression. Biochem Soc Symp. 1998; 63:101-13.
    View in: PubMed
    Score: 0.008
  101. Use of PRKO mice to study the role of progesterone in mammary gland development. J Mammary Gland Biol Neoplasia. 1997 Oct; 2(4):343-54.
    View in: PubMed
    Score: 0.008
  102. TAp63 suppresses mammary tumorigenesis through regulation of the Hippo pathway. Oncogene. 2017 04 27; 36(17):2377-2393.
    View in: PubMed
    Score: 0.007
  103. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016 06; 18(6):632-44.
    View in: PubMed
    Score: 0.007
  104. Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers. Dis Model Mech. 2016 07 01; 9(7):749-57.
    View in: PubMed
    Score: 0.007
  105. A Geometrically-Constrained Mathematical Model of Mammary Gland Ductal Elongation Reveals Novel Cellular Dynamics within the Terminal End Bud. PLoS Comput Biol. 2016 Apr; 12(4):e1004839.
    View in: PubMed
    Score: 0.007
  106. The mammary gland as a bioreactor: factors regulating the efficient expression of milk protein-based transgenes. Am J Clin Nutr. 1996 Apr; 63(4):627S-32S.
    View in: PubMed
    Score: 0.007
  107. Engineering transgenes for use in the mammary gland. Genet Eng (N Y). 1996; 18:57-81.
    View in: PubMed
    Score: 0.007
  108. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(2):347-56.
    View in: PubMed
    Score: 0.007
  109. The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. Cell Rep. 2014 Nov 20; 9(4):1318-32.
    View in: PubMed
    Score: 0.006
  110. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. Stem Cells. 2014 Oct; 32(10):2571-82.
    View in: PubMed
    Score: 0.006
  111. Wnt-responsive cancer stem cells are located close to distorted blood vessels and not in hypoxic regions in a p53-null mouse model of human breast cancer. Stem Cells Transl Med. 2014 Jul; 3(7):857-66.
    View in: PubMed
    Score: 0.006
  112. The regulation of mammary gland development by hormones, growth factors, and oncogenes. Prog Clin Biol Res. 1994; 387:95-111.
    View in: PubMed
    Score: 0.006
  113. Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biol. 2013 Nov 12; 14(11):R125.
    View in: PubMed
    Score: 0.006
  114. Predicting drug responsiveness in human cancers using genetically engineered mice. Clin Cancer Res. 2013 Sep 01; 19(17):4889-99.
    View in: PubMed
    Score: 0.006
  115. Separation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med. 2013 Mar; 2(3):199-203.
    View in: PubMed
    Score: 0.006
  116. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res. 2013 Mar 15; 73(6):1981-92.
    View in: PubMed
    Score: 0.006
  117. Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties. Sci Rep. 2013; 3:2687.
    View in: PubMed
    Score: 0.006
  118. Targeting CreER(T2) expression to keratin 8-expressing murine simple epithelia using bacterial artificial chromosome transgenesis. Transgenic Res. 2012 Oct; 21(5):1117-23.
    View in: PubMed
    Score: 0.005
  119. Activation of Wnt signaling by chemically induced dimerization of LRP5 disrupts cellular homeostasis. PLoS One. 2012; 7(1):e30814.
    View in: PubMed
    Score: 0.005
  120. Casein gene expression: from transfection to transgenics. Cancer Treat Res. 1992; 61:379-97.
    View in: PubMed
    Score: 0.005
  121. Progesterone receptor directly inhibits ?-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. Mol Endocrinol. 2011 Jun; 25(6):955-68.
    View in: PubMed
    Score: 0.005
  122. Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. Breast Cancer Res. 2011 Apr 05; 13(2):R41.
    View in: PubMed
    Score: 0.005
  123. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci U S A. 2011 Mar 01; 108(9):3665-70.
    View in: PubMed
    Score: 0.005
  124. Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. Dev Biol. 2011 Apr 01; 352(1):116-27.
    View in: PubMed
    Score: 0.005
  125. Early-onset aging and defective DNA damage response in Cdc14b-deficient mice. Mol Cell Biol. 2011 Apr; 31(7):1470-7.
    View in: PubMed
    Score: 0.005
  126. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis. Breast Cancer Res. 2010; 12(5):R73.
    View in: PubMed
    Score: 0.005
  127. Genetic manipulation of individual somatic mammary cells in vivo reveals a master role of STAT5a in inducing alveolar fate commitment and lactogenesis even in the absence of ovarian hormones. Dev Biol. 2010 Oct 15; 346(2):196-203.
    View in: PubMed
    Score: 0.005
  128. The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia. 2010 Mar; 15(1):85-100.
    View in: PubMed
    Score: 0.005
  129. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proc Natl Acad Sci U S A. 2010 Feb 23; 107(8):3728-33.
    View in: PubMed
    Score: 0.005
  130. Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival. Cancer Res. 2009 Mar 15; 69(6):2244-51.
    View in: PubMed
    Score: 0.004
  131. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ. Breast Cancer Res. 2009; 11(5):R66.
    View in: PubMed
    Score: 0.004
  132. Mammary gland macrophages: pleiotropic functions in mammary development. J Mammary Gland Biol Neoplasia. 2006 Oct; 11(3-4):229-38.
    View in: PubMed
    Score: 0.004
  133. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. Mol Endocrinol. 2007 Jan; 21(1):106-25.
    View in: PubMed
    Score: 0.004
  134. Isolation and characterization of milk protein nuclear RNAs in rat mammary gland. Anal Biochem. 1986 Mar; 153(2):211-20.
    View in: PubMed
    Score: 0.003
  135. Evolution of the casein multigene family: conserved sequences in the 5' flanking and exon regions. Nucleic Acids Res. 1986 Feb 25; 14(4):1883-902.
    View in: PubMed
    Score: 0.003
  136. Regulatory sequences involved in the hormonal control of casein gene expression. Ann N Y Acad Sci. 1986; 464:87-99.
    View in: PubMed
    Score: 0.003
  137. Multihormonal regulation of milk protein gene expression. Ann N Y Acad Sci. 1986; 478:63-76.
    View in: PubMed
    Score: 0.003
  138. Maintenance of milk protein gene expression in a subpopulation of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinoma cells grown on attached collagen gels. In Vitro Cell Dev Biol. 1985 Aug; 21(8):439-44.
    View in: PubMed
    Score: 0.003
  139. The rat casein multigene family. Fine structure and evolution of the beta-casein gene. J Biol Chem. 1985 Jun 10; 260(11):7042-50.
    View in: PubMed
    Score: 0.003
  140. Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol. 1985; 109:572-92.
    View in: PubMed
    Score: 0.003
  141. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15853-8.
    View in: PubMed
    Score: 0.003
  142. Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice. Cancer Res. 2003 Dec 01; 63(23):8256-63.
    View in: PubMed
    Score: 0.003
  143. Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol Cancer Res. 2003 Dec; 1(14):1036-47.
    View in: PubMed
    Score: 0.003
  144. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer Res. 2003 Oct 01; 63(19):6237-43.
    View in: PubMed
    Score: 0.003
  145. The rat casein multigene family. I. Fine structure of the gamma-casein gene. J Biol Chem. 1983 Sep 10; 258(17):10794-804.
    View in: PubMed
    Score: 0.003
  146. Tissue- and cell-specific casein gene expression. II. Relationship to site-specific DNA methylation. J Biol Chem. 1983 Sep 10; 258(17):10805-11.
    View in: PubMed
    Score: 0.003
  147. Isolation and characterization of casein-producing and -nonproducing cell populations from 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res. 1983 May; 43(5):2199-209.
    View in: PubMed
    Score: 0.003
  148. An inducible system for the study of FGF signalling in early amphibian development. Dev Biol. 2003 Apr 01; 256(1):89-99.
    View in: PubMed
    Score: 0.003
  149. Hormone dependence in premalignant mammary progression. Cancer Res. 2003 Mar 01; 63(5):1067-72.
    View in: PubMed
    Score: 0.003
  150. Sequence of rat alpha- and gamma-casein mRNAs: evolutionary comparison of the calcium-dependent rat casein multigene family. Nucleic Acids Res. 1982 Dec 20; 10(24):8079-98.
    View in: PubMed
    Score: 0.003
  151. The mineralocorticoid receptor may compensate for the loss of the glucocorticoid receptor at specific stages of mammary gland development. Mol Endocrinol. 2002 Sep; 16(9):2008-18.
    View in: PubMed
    Score: 0.003
  152. Comparative sequence analysis of the mRNAs coding for mouse and rat whey protein. Nucleic Acids Res. 1982 Jun 25; 10(12):3733-44.
    View in: PubMed
    Score: 0.003
  153. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 2002 May 01; 245(1):42-56.
    View in: PubMed
    Score: 0.003
  154. Rat beta casein cDNA: sequence analysis and evolutionary comparisons. Nucleic Acids Res. 1982 Apr 10; 10(7):2295-307.
    View in: PubMed
    Score: 0.003
  155. Complex hormonal regulation of rat casein gene expression. J Biol Chem. 1982 Apr 10; 257(7):3598-605.
    View in: PubMed
    Score: 0.003
  156. Hormonal induction of casein gene expression limited to a small subpopulation of 7,12-dimethylbenz(a)anthracene-induced mammary tumor cells. Cancer Res. 1982 Apr; 42(4):1355-60.
    View in: PubMed
    Score: 0.003
  157. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol Endocrinol. 2002 Mar; 16(3):563-70.
    View in: PubMed
    Score: 0.003
  158. Mechanisms of hormonal prevention of breast cancer. Ann N Y Acad Sci. 2001 Dec; 952:23-35.
    View in: PubMed
    Score: 0.003
  159. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol. 2001 Nov 12; 155(4):531-42.
    View in: PubMed
    Score: 0.003
  160. Tumor-specific polyadenylated RNA's from 7,12-dimethylbenz(a)anthracene-induced mammary tumors revealed through hybridization with fractionated single-copy DNA. Cancer Res. 1981 Oct; 41(10):3827-34.
    View in: PubMed
    Score: 0.003
  161. Restriction enzyme mapping and heteroduplex analysis of the rat milk protein cDNA clones. J Biol Chem. 1981 Jan 10; 256(1):533-8.
    View in: PubMed
    Score: 0.002
  162. Construction and preliminary characterization of the rat casein and alpha-lactalbumin cDNA clones. J Biol Chem. 1981 Jan 10; 256(1):526-32.
    View in: PubMed
    Score: 0.002
  163. Gene expression in normal and neoplastic mammary tissue. Biochemistry. 1980 Jul 22; 19(15):3452-60.
    View in: PubMed
    Score: 0.002
  164. Long term effects of perinatal injection of estrogen and progesterone on the morphological and biochemical development of the mammary gland. Endocrinology. 1980 Mar; 106(3):823-32.
    View in: PubMed
    Score: 0.002
  165. Prolactin regulation of casein gene expression: possible mediators. Endocrinology. 1980 Jan; 106(1):252-9.
    View in: PubMed
    Score: 0.002
  166. Multihormonal regulation of casein gene expression at the transcriptional and posttransciptional levels in the mammary gland. Recent Prog Horm Res. 1980; 36:157-93.
    View in: PubMed
    Score: 0.002
  167. Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell. 1979 Aug; 17(4):1013-23.
    View in: PubMed
    Score: 0.002
  168. Prolactin induction of casein mRNA in organ culture. A model system for studying peptide hormone regulation of gene expression. J Biol Chem. 1978 Apr 10; 253(7):2343-7.
    View in: PubMed
    Score: 0.002
  169. Progesterone-mediated inhibition of casein mRNA and polysomal casein synthesis in the rat mammary gland during pregnancy. Biochemistry. 1978 Jan 24; 17(2):290-7.
    View in: PubMed
    Score: 0.002
  170. Detection of casein messenger RNA in hormone-dependent mammary cancer by molecular hybridisation. Nature. 1977 Sep 01; 269(5623):83-6.
    View in: PubMed
    Score: 0.002
  171. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice. Mol Cell Biol. 1997 Jun; 17(6):3155-63.
    View in: PubMed
    Score: 0.002
  172. Quantitation of casein messenger ribonucleic acid sequences using a specific complementary DNA hybridization probe. Biochemistry. 1976 Nov 30; 15(24):5272-80.
    View in: PubMed
    Score: 0.002
  173. Isolation and characterization of purified rat casein messenger ribonucleic acids. Biochemistry. 1976 Nov 30; 15(24):5263-71.
    View in: PubMed
    Score: 0.002
  174. Regulation of casein messenger RNA during the development of the rat mammary gland. Biochemistry. 1975 Jul; 14(13):2895-903.
    View in: PubMed
    Score: 0.002
  175. Effect of estrogen on the synthesis and processing of ovalbumin messenger RNA in the chick oviduct. Brookhaven Symp Biol. 1975 Jul; (26):320-32.
    View in: PubMed
    Score: 0.002
  176. Preparation and preliminary characterization of purified ovalbumin messenger RNA from the hen oviduct. Biochemistry. 1975 Jan 14; 14(1):69-78.
    View in: PubMed
    Score: 0.002
  177. Effect of estrogen on gene expression in the chick oviduct. 3. Hybridization studies with (3H) messenger RNA and (3H) complementary DNA under conditions of DNA excess. Cell Differ. 1974 Jul; 3(2):103-16.
    View in: PubMed
    Score: 0.002
  178. Effect of estrogen on gene expression in the chick oviduct. I. Deoxyribonucleic acid--deoxyribonucleic acid renaturation studies. Biochemistry. 1973 Jul 17; 12(15):2803-9.
    View in: PubMed
    Score: 0.001
  179. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells. Cancer Res. 1972 Mar; 32(3):511-5.
    View in: PubMed
    Score: 0.001
  180. Inhibitory effect of cortisol in vitro on 2-deoxyglucose uptake and RNA and protein metabolism in lymphosarcoma P1798. Cancer Res. 1972 Feb; 32(2):350-5.
    View in: PubMed
    Score: 0.001
  181. A comparison of the effect of glucocorticoids on glucose uptake and hexokinase activity in lymphosarcoma P1798. Biochim Biophys Acta. 1970 Dec 01; 219(2):447-54.
    View in: PubMed
    Score: 0.001
  182. Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid. J Biol Chem. 1970 Apr 25; 245(8):2074-80.
    View in: PubMed
    Score: 0.001
  183. Effects of cortisol on DNA metabolism in the sensitive and resistant lines of mouse lymphoma P1798. Cancer Res. 1970 Apr; 30(4):1129-36.
    View in: PubMed
    Score: 0.001
  184. Comparison of the whey acidic protein genes of the rat and mouse. Nucleic Acids Res. 1984 Nov 26; 12(22):8685-97.
    View in: PubMed
    Score: 0.001
  185. Localization of the casein gene family to a single mouse chromosome. J Cell Biol. 1982 Apr; 93(1):199-204.
    View in: PubMed
    Score: 0.001
  186. Difference between mammary epithelial cells from mature virgin and primiparous mice. Cancer Res. 1978 Nov; 38(11 Pt 2):4059-65.
    View in: PubMed
    Score: 0.001
  187. Mammary tumour virus and casein gene transcription during mouse mammary development. Nature. 1978 Oct 05; 275(5679):455-7.
    View in: PubMed
    Score: 0.001
  188. Processing of nuclear heterogeneous RNA: recent developments. Life Sci. 1977 Jan 01; 20(1):1-15.
    View in: PubMed
    Score: 0.000
  189. Use of a specific probe for ovalbumin messenger RNA to quantitate estrogen-induced gene transcripts. Biochemistry. 1975 May 20; 14(10):2072-81.
    View in: PubMed
    Score: 0.000
  190. Use of Sepharose 4B for preparative scale fractionation of eukaryotic messenger RNA's. Prep Biochem. 1974; 4(6):555-72.
    View in: PubMed
    Score: 0.000
  191. Effect of estrogen on gene expression in the chick oviduct. II. Transcription of chick tritiated unique deoxyribonucleic acid as measured by hybridization in ribonucleic acid excess. Biochemistry. 1973 Jul 17; 12(15):2809-16.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.